Showing results (461-470 of 612) with videos related to

Sort By:
Pageof 62
The Journal of Allergy and Clinical Immunology. in Practice|December 20, 2023
Once-Daily Oral Berotralstat for Long-Term Prophylaxis of Hereditary Angioedema: The Open-Label Extension of the APeX-2 Randomized TrialSorena Kiani-Alikhan, Richard Gower, Timothy Craig, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Biomni: A General-Purpose Biomedical AI AgentKexin Huang, Serena Zhang, Hanchen Wang, et al.
Orphanet Journal of Rare Diseases|February 16, 2021
Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension studyWilliam R Lumry, Bruce Zuraw, Marco Cicardi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 3, 2018
Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary AngioedemaWilliam R Lumry, Timothy Craig, Bruce Zuraw, et al.
The Journal of Allergy and Clinical Immunology|June 4, 2013
A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedemaBruce L Zuraw, Jonathan A Bernstein, David M Lang, et al.
Advances in Therapy|June 12, 2025
Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World StudyJonathan A Bernstein, Stephen D Betschel, Paula J Busse, et al.
The Journal of Allergy and Clinical Immunology|April 29, 2014
The diagnosis and management of acute and chronic urticaria: 2014 updateJonathan A Bernstein, David M Lang, David A Khan, et al.
Medrxiv : the Preprint Server for Health Sciences|September 5, 2025
Biallelic variants in RNU2-2 cause the most prevalent known recessive neurodevelopmental disorderDaniel Greene, Rodrigo Mendez, Jon Lees, et al.
Clinical and Translational Allergy|March 4, 2026
An International Delphi Study on Barriers to On-Demand Treatment of Hereditary Angioedema AttacksAleena Banerji, Emel Aygören-Pürsün, Noemi-Anna Bara, et al.
The World Allergy Organization Journal|October 18, 2021
Dogmas, challenges, and promises in phase III allergen immunotherapy studiesPieter-Jan De Kam, Matthias F Kramer, Mohamed H Shamji, et al.
Pageof 62